What a Real Weight-Loss Curve Looks Like: Fast Start, Plateaus and Weeks the Scale Goes Up

The shape, from the trials

• Semaglutide (STEP 1 trial, about 1,900 adults): average loss of 14.9% of body weight at 68 weeks, compared with 2.4% on placebo. The steepest loss came in the first 20 weeks. The curve flattened around week 60.
• Tirzepatide (SURMOUNT-1 trial, about 2,500 adults): average loss of 15% to 20.9% at 72 weeks, depending on the dose group. Again the steepest loss came early, with a gradual flattening after about a year.
• Retatrutide (phase 2 trial, 338 adults): average loss of up to 24.2% at 48 weeks in the highest dose group, with weight still falling when the study ended. Retatrutide is an investigational drug. It is not approved by the FDA, and it is not available as a prescription.

These are averages. Within every trial some people lost much more, some much less, and no individual's chart was a straight line.

Phase 1: the fast start

The first weeks usually show the largest drops. Part of that is fat. Part is water. When you eat less, especially fewer carbohydrates, the body uses up stored glycogen, and each gram of glycogen is stored with about three grams of water. Less food in the gut and less salt also lower the number. Early results are encouraging, and they are not the pace the rest of the program will keep.

Phase 2: the steady middle

After the first month or two, loss settles to a slower weekly average. This is where most of the fat loss happens. It is also where the week-to-week numbers get noisy.

Why the scale goes up some weeks

Body weight normally moves 2 to 4 pounds from day to day without any change in body fat. On a single weigh-in, that noise can hide or reverse a week of real progress. The usual reasons:

• Salt. A salty meal can hold a pound or two of water for a couple of days.
• Carbohydrates. A higher-carb day refills glycogen and the water stored with it.
• Constipation. It is a common side effect of GLP-1 medications.
• The menstrual cycle. Water retention before a period commonly adds a few pounds.
• Hard exercise. Sore muscles hold water while they repair.
• Alcohol, travel, poor sleep and stress.
• Timing. Weighing at a different time of day, or after eating, changes the reading.

A higher number one week almost never means fat was gained. Gaining a single pound of fat takes eating roughly 3,500 calories more than you burn.

How to read your own chart

• Weigh at the same time, in the same conditions. First thing in the morning is most consistent.
• Look at the weekly average, or the trend across four weeks. Ignore single days.
• Track waist measurement and how clothes fit. They often change in weeks when the scale does not.
• Expect several flat or up weeks over a year. They are part of a normal curve.

Why loss slows down

• A smaller body burns less. At a lower weight you need fewer calories, so the same eating pattern produces a smaller deficit.
• The body adapts. As fat is lost, the hormone leptin falls, hunger signals rise and energy use drops somewhat more than the weight change alone would predict.
• Muscle loss. Some of the weight lost is lean tissue, which lowers energy use further. Enough protein and resistance training limit this.
• Habits drift. Portions and snacks tend to creep back as the early motivation fades.

Why a provider increases the dose slowly

GLP-1 medications are started low and stepped up over weeks to months. The main reason is side effects. Nausea, vomiting, diarrhea and constipation are most common right after each increase, and going up gradually makes them milder and shorter. In the trials, reaching the full dose took 16 to 20 weeks.

A slow step-up also means you stay at the lowest dose that is still working. A flat week is not, by itself, a reason to increase. The provider looks at the trend over several weeks, how you are tolerating the medication, and your lab results before changing anything. Going faster does not produce better results, and it produces more side effects.

The plateau

Every curve flattens. In the trials this happened after about a year or more. A plateau means the body has reached a new balance on that treatment. It is a normal endpoint, and holding a lower weight is the goal at that stage.

When a plateau arrives early, a provider checks protein intake, activity and strength training, sleep, alcohol, other medications, and whether a change in dose or medication is appropriate.

What happens if you stop

In a follow-up of the semaglutide trial, people who stopped the medication regained about two thirds of the weight they had lost within a year. This is why a plan for maintenance, or for coming off gradually under supervision, matters as much as the plan for losing.

How our program handles this

Our weight-loss programs are physician-led. A licensed provider reviews your health history and lab work before anything is prescribed. Increases are gradual. Check-ins are monthly, with messaging in between, and nutrition guidance is included. We offer only medications that can be legally prescribed. We serve all of New York & New Jersey, and our medical director oversees every treatment.

Quick answers

Is it normal for the scale to go up while on a GLP-1? Yes. Day-to-day water shifts of a few pounds are normal and do not reflect fat gain.

How fast should I expect to lose? Trials show averages of about 15% to 21% of body weight over about 16 months on approved medications, with the fastest loss early.

How long does a plateau last? A flat stretch of two to four weeks is common. A longer one is worth a conversation with your provider.

Should my dose go up when I stall? Not automatically. The provider decides based on the trend, side effects and labs.

Will I lose muscle? Some lean mass is lost with any significant weight loss. Protein and resistance training reduce it.

Can I get retatrutide? No. It is investigational and not FDA approved.

Want a program with a provider watching the trend with you? See zenivspa.com/glp/.

All treatments are medical services. Every guest is screened, and every treatment is provided only under the clearance, prescription or standing protocol of a licensed medical provider. Compounded peptides are not FDA-approved unless stated. Nothing on this page is a diagnosis or a promise of results.